Healthcare companies in the flowable hemostats market are increasing the supply of life-sustaining medicines and medical devices such as flowable hemostats amidst dire times of the coronavirus pandemic. Read More
Related Posts
Induced Pluripotent Stem Cells Market in 2021 | Expansive Analysis Report
Induced pluripotent stem cells hold profound potential in replacing the use of embryonic stem cells as important tool…
Abbott Wins $750 Million Contract with U.S. Government for Rapid COVID-19 Test
Published: Aug 28, 2020
By Alex Keown
One…
InteRNA Technologies Publishes Preclinical Data from Investigational microRNA INT-1B3 Program in Molecular Therapy – Nucleic Acids and Oncotarget
Results further support the potential of lead candidate, INT-1B3, as novel option for therapeutic intervention in oncology Read…